Investigation Initiated Against Organon & Co. by Former Louisiana Attorney General Charles C. Foti, Jr.

Organon & Co. (NYSE: OGN) is being investigated by former Louisiana Attorney General Charles C. Foti, Jr. on behalf of investors. The investigation concerns allegations of fraud, negligence, or other unlawful business practices. The investigation was initiated after the company disclosed the resignation of CEO Kevin Ali following an internal investigation that revealed certain U.S. wholesalers were asked to purchase additional Nexplanon to meet guidance and external revenue expectations. Investors who have suffered losses are advised to contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email.